Paul Hastings Advised Barclays, Other Initial Purchasers in Connection With Surgery Partners' $800M High Yield Senior Notes Offering
May 09, 2024
May 09, 2024
LOS ANGELES, California, May 9 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised Barclays and the other initial purchasers in connection with Surgery Partners' high yield senior notes offering for $800 million.
The net proceeds from the offering are being used to redeem all of Surgery Partners' outstanding 6.750% senior unsecured notes due 2025 and 10.000% senior unsecured notes due 2027, to pay the accrued interest on such notes, and to . . .
Paul Hastings LLP advised Barclays and the other initial purchasers in connection with Surgery Partners' high yield senior notes offering for $800 million.
The net proceeds from the offering are being used to redeem all of Surgery Partners' outstanding 6.750% senior unsecured notes due 2025 and 10.000% senior unsecured notes due 2027, to pay the accrued interest on such notes, and to . . .